The Current Evidence for the Use of Safinamide for the Treatment of Parkinson’s Disease
Giovanni Abbruzzese,1 Paolo Barone,2 Leonardo Lopiano,3 Fabrizio Stocchi4 1Department of Neuroscience, University of Genova, Genova, Italy; 2School of Medicine, University of Salerno, Salerno, Italy; 3Department of Neuroscience, University of Turin, AOU Città della Salute e della Scienza,...
Saved in:
Main Authors: | Abbruzzese G (Author), Barone P (Author), Lopiano L (Author), Stocchi F (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adjuvant therapies for Parkinson’s disease: critical evaluation of safinamide
by: Stocchi F, et al.
Published: (2016) -
Safinamide in the management of patients with Parkinson’s disease not stabilized on levodopa: a review of the current clinical evidence
by: Bette S, et al.
Published: (2018) -
Emerging approaches in Parkinson’s disease – adjunctive role of safinamide
by: Müller T
Published: (2016) -
Safinamide: an add-on treatment for managing Parkinson’s disease
by: Müller T
Published: (2018) -
Investigational agents in the treatment of Parkinson's disease: focus on safinamide
by: Malek NM, et al.
Published: (2012)